Approved by the Food and Drug Administration in 2009 for treatment of type 2 diabetes, bromocriptine, under the brand name of Cycloset, is a drug used to manage blood glucose through brain signals and the central nervous system. It has been shown to reduce HbA1c levels and inhibit the release of glutamate. It is a dopamine agonist used for many years to treat certain types of pituitary tumors and more recently, for Parkinson’s disease. An agonist is a chemical that binds to a cell’s receptor to trigger a response, often by mimicking the action of a substance that occurs naturally in the body. It was found in studies that dopamine levels were low in people with metabolic disease, which contributes to conditions such as insulin resistance.

Bromocriptine Side Effects: What Are The Risks?

In the treatment of diabetes, bromocriptine side effects can include indigestion, stomach cramps, nausea …